Scarica l'app Stockscreener
1.94
1.52%
-0.03
Dopo l'orario di chiusura:
1.94
Precedente Chiudi:
$1.97
Aprire:
$1.91
Volume 24 ore:
86,279
Relative Volume:
0.33
Capitalizzazione di mercato:
$2.83B
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-8.6337
EPS:
-0.2247
Flusso di cassa netto:
-
1 W Prestazione:
-4.43%
1M Prestazione:
+19.75%
6M Prestazione:
+0.78%
1 anno Prestazione:
-35.12%
Intervallo 1D:
$1.8793
$1.98
Intervallo di 1 settimana:
$1.8793
$2.23
Portata 52W:
$1.32
$3.12
Immutep Limited Adr Stock (IMMP) Company Profile
Nome
Immutep Limited Adr
Settore
Industria
Telefono
-
Indirizzo
-
Confronta IMMP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IMMP
Immutep Limited Adr
|
1.94 | 288.21M | 0 | 0 | 0 | 0.00 |
|
ONC
Beigene Ltd Adr
|
241.43 | 24.41B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
436.00 | 111.55B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.335 | 42.47M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
588.34 | 63.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
75.06 | 5.92B | 0 | -153.72M | -103.81M | -2.00 |
Immutep Limited Adr Stock (IMMP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-05-17 | Iniziato | CapitalOne | Overweight |
| 2023-08-03 | Iniziato | Robert W. Baird | Outperform |
| 2021-08-03 | Iniziato | Ladenburg Thalmann | Buy |
| 2021-07-16 | Ripresa | Maxim Group | Buy |
| 2018-09-28 | Iniziato | B. Riley FBR | Buy |
| 2018-02-15 | Reiterato | Maxim Group | Buy |
Mostra tutto
Immutep Limited Adr Borsa (IMMP) Ultime notizie
Market Highlights: Immutep Limited ADR (IMMP) Ends on a Low Note at 1.93 - DWinneX
Immutep stock soars on promising trial results By Investing.com - Investing.com Nigeria
Immutep stock soars on promising trial results - Investing.com Australia
Immutep Quarterly Activities Report Q3 FY25 - The Manila Times
Immutep to Participate in Upcoming Investor Conferences - GlobeNewswire Inc.
Immutep Limited (ASX:IMM) Initiates Phase III Trial for Non-Small Cell Lung Cancer - thecapitalclub.com.au
Is Immutep Limited (IMMP) the Best Long Term ASX Stock to Buy Now? - AInvest
Immutep Limited (NASDAQ:IMMP) Shares Sold by Jane Street Group LLC - Defense World
Verition Fund Management LLC Has $57,000 Stock Position in Immutep Limited (NASDAQ:IMMP) - Defense World
Immutep Announces Initial Safety Data from First-in-Human Phase I Trial Evaluating IMP761 - The Manila Times
Immutep shares new cancer study results - Investing.com
Immutep Quarterly Activities Report Q1 FY25 - Yahoo Finance
Immutep Announces First-in-Human Phase I Study of IMP761 Progresses to Dose Escalation Portion of Trial - Yahoo Finance
Immutep Announces Successful Meeting with FDA on Phase III Design in Non-Small Cell Lung Cancer - GlobeNewswire
Baird cuts Immutep stock target on phase 2b trial results, retains Outperform - Investing.com
Immutep Appoints Leading Research Institute to Conduct First-in-Human Phase I Study of IMP761 - GlobeNewswire
10 Best Australian Stocks To Buy - Yahoo Finance
Immutep Announces Expansion of Triple Combination Therapy in 1st Line Non-Small Cell Lung Cancer - GlobeNewswire
Check Up: These 4 ASX healthcare stocks come with Strong Buy recommendations - Stockhead
ICE Announces Annual Reconstitution Changes in the ICE Biotechnology Index - Business Wire
FDA Grants Fast Track Designation to 1L Eftilagimod Alpha for Recurrent or Metastatic HNSCC - Targeted Oncology
Best Penny Stocks To Buy For 2021? 5 Biotech Stocks To Watch - Penny Stocks
IMMPImmutep Latest Stock News & Market Updates - Stock Titan
The Daily Biotech Pulse: Moderna To Kickstart Phase 3 Study On July 27, Immutep Awarded Antibody Patent - Yahoo Finance
Immutep Ltd (IMMP) Stock Price, Trades & News - GuruFocus
A Full List of Australia ADRs - Investing.com Australia
Immutep (IMMP) Stock Price, News & Analysis - MarketBeat
Prima BioMed Share Price | NASDAQ IMMP Stock - Investing.com Australia
Prima BioMed Stock Price Today | NASDAQ: IMMP Live - Investing.com
Prima BioMed Stock Price Today | NASDAQ IMMP - Investing.com Canada
ADVFN | Live Stock, Options & Crypto Market Data, Trading Tools & Community - advfn.com
Immutep Limited Adr Azioni (IMMP) Dati Finanziari
Non sono disponibili dati finanziari per Immutep Limited Adr (IMMP). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
17.27%
1.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):